Research Article

A Preliminary Study of Uric Metabolomic Alteration for Postpartum Depression Based on Liquid Chromatography Coupled to Quadrupole Time-of-Flight Mass Spectrometry

Table 2

The differentiating metabolites contributing to the discrimination of urine metabolomic profiles of postpartum depressed patients and healthy controls in the training group.

MetaboliteRT (min)Ion modeMS ()MS/MS ()VIP value value valueTrendFold changecAUC (95% CI)SensitivitySpecificity

Alanine1.7[M+H]+90.0557442.97<0.0010.007Upa1.180.722 (0.621-0.827)0.6750.675
Methylmalonic acid1.4[M-H]-117.0191734.28<0.001<0.001Up1.520.848 (0.744-0.918)0.7250.825
Homocysteine3.4[M+H]+136.0427118, 904.30<0.0010.012Up1.620.852 (0.770-0.931)0.7750.800
Tyrosine3.3[M+H]+182.0804165, 136, 914.38<0.0010.048Downb-1.480.859 (0.761-0.920)0.7000.850
Glutaric acid1.6[M-H]-131.034687, 592.77<0.0010.019Up1.310.711 (0.587-0.816)0.6250.775
Vanillylmandelic acid1.9[M-H]-197.04501374.33<0.0010.029Up1.420.851 (0.762-0.918)0.7500.750
4-Hydroxyhippuric acid3.8[M-H]-194.0461150, 934.71<0.001<0.001Up1.380.884 (0.806-0.946)0.8250.825
4-Hydroxybenzoic acid3.6[M-H]-137.0231932.64<0.0010.033Up1.110.714 (0.599-0.831)0.6500.725
5-Hydroxyindoleacetic acid4.9[M+H]+192.0647146, 1183.39<0.001<0.001Up1.350.752 (0.650-0.836)0.7250.650
3-(3-Hydroxyphenyl)-3-hydroxypropionic acid2.2[M-H]-181.0499137, 1194.16<0.001<0.001Up1.630.827 (0.725-0.907)0.8250.725

RT: retention time; VIP: variable importance in the projection; CI: confidence interval. aThe level in patients is higher than that in controls. bThe level in patients is lower than that in controls. cThe fold change was calculated by dividing the level of metabolite in patients by that in controls.